Emory Technology Transfer presents 13th Celebration of Technology & Innovation
Tuesday, March 12, 2019 12:00 AM

Emory University’s Office of Technology Transfer will celebrate its faculty entrepreneurs and their innovative discoveries at the 13th Annual Celebration of Technology and Innovation.

The celebration will be held Thursday, March 21, 2019 at the Emory Conference Center, Silver Bell Pavilion, 1615 Clifton Rd., Atlanta, GA 30322.

Registration begins at 4:30 p.m., and the program begins at 5 p.m., followed by a reception.

RSVP here!

For questions, contact Quentin Thomas: [email protected], 404-727-1899

Learn more here

 
Senate Moves to Stop $20 Billion Tax Increase on MedTech Industry
Thursday, March 07, 2019 11:13 AM

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation the Protect Medical Innovation Act  in the U.S. Senate to permanently repeal the medical device excise tax: 

“Unless Congress acts quickly, America’s medical technology companies face a $20 billion tax hike at the end of 2019 when the device excise tax returns. If not stopped, this tax will put future patient innovations and good-paying U.S. jobs at risk. 

“Today’s Senate action is the first step in ensuring continued American leadership of this vital industry. We thank the bill’s lead sponsors, Sens. Pat Toomey (R-Pa.) and Amy Klobuchar (D-Minn.), for their long-standing support of improving patient lives and medtech innovation. The broad bipartisan backing of this bill reflects members’ understanding of the negative impact on job creation, investment and patient care should this tax return, and the urgent need for repeal. 

Read more...
 
GeoVax and Leidos Expand Collaboration to Malaria Vaccines
Monday, March 04, 2019 10:24 AM

ATLANTA, GA, March 4, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it has expanded its collaboration activities with Leidos, Inc. to develop malaria vaccine candidates. The work will be supported under a contract to Leidos from the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP). Leidos has been tasked by USAID to advance promising vaccine candidates against P. falciparum malaria and selected the GeoVax MVA-VLP platform as part of this development effort.

GeoVax’s vaccine technology is based on its live Modified Vaccinia Ankara (MVA) platform, which generates vaccine antigens, in the form of multimeric proteins or noninfectious VLPs, in the individual being vaccinated. Gene sequences of target antigens are inserted into the MVA genome which drives their expression and budding from the infected cells. In this way, vaccination strategy mimics a natural viral infection which induces two pools of proteins – virus-infected cells and released multimeric or VLP proteins.

Read more...
 
Georgia Research Alliance 'at a pivot point,' refocusing for the future
Friday, February 15, 2019 12:00 AM

By Maria Saporta  – Contributing Writer, Atlanta Business Chronicle 

Leaders behind the Georgia Research Alliance are seeking to gain traction under the administration of newly-elected Gov. Brian Kemp

The Alliance, launched during the administration of the late Gov. Zell Miller, is a well-respected organization of top business, university and government leaders dedicated to increasing the state’s technology portfolio.

At its quarterly board meeting Feb. 7, a combination of old and new faces were present. David Ratcliffe, retired CEO of Southern Co., was named board chairman – a role he had held in 2005. It also was Russell Allen’s first board meeting as president and CEO of the organization. 

“We are on the verge of taking this to the next level,” Ratcliffe said. “I think we are at a pivot point with a new administration and a new focus." 

Already Ratcliffe, Allen and Mark Sanders, who is GRA’s lobbyist and a longtime friend of the new governor, have met with Kemp, who has promised to attend future meetings. Ratcliffe said Kemp understands the success the Alliance has had over the years and appears open to exploring new opportunities to work with the organization.

Read more...
 
An inside look at the policy issues Georgia Bio is tackling in 2019
Wednesday, February 13, 2019 04:43 PM

As Georgia welcomes its new Governor and a wave of newly elected legislators, we asked Kallarin Mackey, Emory University Director of State Affairs, Government and Community Affairs and Joseph (Joe) Zorzoli, Head of U.S. Government Relations for UCB to weigh in on the state of play in life sciences policy in Georgia.

How does Georgia Bio plan to work with the incoming Governor and newly elected legislators to ensure they are aware of the important issues of the life sciences industry? 

KALLARIN: It will be important to begin by educating the newly elected officials on who Georgia Bio is as an organization, the issues that are important to the membership and the impact that the life sciences industry has on our state. Georgia’s bioscience firms have grown their employment base by 10.6 percent since 2014 and employed just over 32,000 in 2016. To the point above, one of the best ways to illustrate this is by bringing legislators on site to see the work that Georgia Bio members are doing across the state. It’s important to make it personal. Seeing in person the research and innovation that Georgia Bio members engage in every day is a great way to help a lawmaker understand the impact that these companies have in their own district and across the state.

Regarding workforce development, Georgia’s life science industry is consistently seeing a shortage of employees with necessary skills to fill jobs. One example is biomanufacturing. Our research universities, through federal, private and state funding, have advanced their bio manufacturing centers and programs helping to position Georgia as a leader in the future of biotechnology in medicine, agriculture and industrial applications. However, many of our high school students don’t have the opportunity to learn and advance into these degree programs. 

Read more...
 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 10 of 49